Tardive Dyskinesia
📧 Sign up to get email alerts when something new happens for Tardive Dyskinesia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: The Assessment of Movement Disorders Utilizing Live Two-Way Video
This clinical trial update reports on assessing movement disorders in tardive dyskinesia using live two-way video and the study has complete…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Melatonin Treatment for Tardive Dyskinesia in Schizophrenia [NA]
This completed clinical trial evaluated melatonin as a treatment for tardive dyskinesia in individuals with schizophrenia.
-
FDA approval · 2015-06-03FDA Approved: XENAZINE — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for XENAZINE (tetrabenazine) submitted by Lundbeck Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Levetiracetam Treatment of Tardive Dyskinesia [Phase 3]
Phase 3 trial of levetiracetam for tardive dyskinesia completed; sponsor Yale University.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia [Phase 2]
Phase 2 trial evaluating levetiracetam for neuroleptic-induced tardive dyskinesia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-07-25Clinical Trial Update: Pyridoxal Kinase Activity in Tardive Dyskinesia [Phase 3]
Phase 3 clinical trial evaluating pyridoxal kinase activity in tardive dyskinesia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia [Phase 1, Phase 2]
A completed Phase 1/Phase 2 study assessed whether Panax ginseng can enhance the efficacy of antipsychotics in schizophrenia and schizoaffec…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia [Phase 2]
A Phase 2 study assessing the efficacy and safety of NBI-98854 in tardive dyskinesia has been completed.
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Piracetam for Treatment Tardive Dyskinesia [Phase 3]
Phase 3 clinical trial update evaluating piracetam for tardive dyskinesia has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-24Clinical Trial Update: Tardive Dyskinesia and Cognitive Function [Phase 4]
Phase 4 clinical trial update from Taipei Veterans General Hospital indicates the study examining tardive dyskinesia and neurocognitive func…
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia [Phase 4]
A Phase 4 study evaluating aripiprazole for neuroleptic-induced tardive dyskinesia is being tracked, with the current trial status listed as…
-
CLINICAL_TRIALS trial_result · 2008-05-06Clinical Trial Update: Extract of Ginkgo Biloba and Tardive Dyskinesia [Phase 3]
Phase 3 clinical trial evaluating a Ginkgo biloba extract for tardive dyskinesia (in patients with schizophrenia) has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-22Clinical Trial Update: Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia [Phase 2]
Phase 2 clinical trial evaluating the efficacy of docosahexaenoic acid for tardive dyskinesia.
-
CLINICAL_TRIALS trial_result · 2008-02-22Clinical Trial Update: Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia [Phase 4]
Phase 4 trial update evaluating risperidone and olanzapine in schizophrenic patients with neuroleptic-induced tardive dyskinesia; study comp…
-
CLINICAL_TRIALS trial_result · 2007-05-02Clinical Trial Update: The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial [Phase 4]
Phase 4 trial update evaluating aripiprazole with a focus on monitoring serum prolactin levels over 3 months in schizophrenia and related co…